Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mark Bower(Chelsea and Westminster Hospital)
Cited by 582
Related Papers
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer
|Annals of Oncology|2022|100
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
|Journal of Thoracic Oncology|2023|91